Ozempic
Semaglutide · Type 2 Diabetes
FDA Approved (T2D)
GLP-1DiabetesWeight LossWeekly
Ozempic is once-weekly subcutaneous semaglutide approved for type 2 diabetes management. Maximum approved dose is 2mg weekly. Widely prescribed off-label for weight loss. Produced by Novo Nordisk.
Semaglutide calculator →
Wegovy
Semaglutide · Chronic Weight Management
FDA Approved (Obesity)
GLP-1ObesityWeight LossWeekly
Wegovy is once-weekly subcutaneous semaglutide approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. Reaches a higher 2.4mg maintenance dose.
Semaglutide calculator →
The Real Difference
Ozempic and Wegovy are pharmacologically identical -- same molecule, same mechanism, same side effects. The only meaningful differences are the maximum dose ceiling (2mg vs 2.4mg), the FDA indication, and insurance coverage. Wegovy reaches a slightly higher dose which accounts for its marginally better weight loss outcomes. If your goal is weight loss and you are using compounded semaglutide, the distinction is irrelevant -- you set the dose yourself. If you are using branded versions, Wegovy is the indicated choice for weight management and may be covered by different insurance plans.
Frequently Asked Questions
What is the difference between Ozempic and Wegovy?
Ozempic and Wegovy are the same drug (semaglutide) made by Novo Nordisk. Ozempic is FDA approved for type 2 diabetes at up to 2mg weekly. Wegovy is FDA approved for chronic weight management at up to 2.4mg weekly. Same molecule, different approved dose and indication.
Which causes more weight loss, Ozempic or Wegovy?
Wegovy produces slightly more weight loss on average (~15% body weight) vs Ozempic (~9--14%) because it reaches a higher maintenance dose of 2.4mg vs 2mg. The difference is real but modest.
Can I use Ozempic for weight loss?
Yes. Ozempic is widely prescribed off-label for weight loss. It produces meaningful weight loss at its 1--2mg dose range. The main downside vs Wegovy is a slightly lower dose ceiling and different insurance coverage.
Is Wegovy just a higher dose of Ozempic?
Essentially yes. Both are once-weekly subcutaneous semaglutide injections. Wegovy received a separate FDA approval at the 2.4mg dose specifically for obesity treatment. The pens and titration schedules differ slightly to accommodate the higher dose range.
Why is Wegovy more expensive?
Wegovy has a separate FDA approval for obesity and uses higher-dose delivery devices. List price for both is $900--1400/month without insurance. Insurance coverage varies significantly -- Ozempic is more commonly covered for T2D patients, Wegovy for obesity treatment.